Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 1,142.12%415.06K | 413.84%361.15K | 103.59%224.35K | 84.76%-202.95K | -191.27%-231.48K | 111.12%33.42K | 87.36%-115.08K | 129.43%110.19K | -88.47%-1.33M | 205.15%253.62K |
| Net income from continuing operations | 701.00%9.32M | 43.41%2.28M | -20.36%-518.59K | 261.08%5.9M | 389.20%3.58M | 220.53%1.16M | 208.88%1.59M | -76,296.81%-430.88K | 65.06%-3.66M | 82.83%-1.24M |
| Operating gains losses | 54.23%-151.07K | 136.90%159.9K | 49.73%-106.23K | -104.45%-39.18K | 49.20%935.52K | -180.61%-330.03K | -603.43%-433.37K | 12.83%-211.31K | 212.21%880.11K | 1,015.14%627.01K |
| Depreciation and amortization | 0.00%33.82K | 0.00%33.82K | 0.00%33.82K | -5.62%135.27K | 0.00%33.82K | -7.36%33.82K | -7.36%33.82K | -7.36%33.82K | -1.84%143.32K | -7.36%33.82K |
| Asset impairment expenditure | --0 | ---- | ---- | -67.92%408.3K | --408.3K | --0 | ---- | ---- | 10,668.97%1.27M | ---- |
| Unrealized gains and losses of investment securities | -1,422.02%-8.37M | -197.25%-2.6M | 9.65%897.82K | -336.83%-5.45M | -2,635.03%-4.84M | -195.31%-550.13K | -147.20%-875.42K | 1,678.22%818.8K | -76.23%2.3M | -102.79%-177.05K |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 86.27%135.11K | --0 |
| Other non cashItems | -806.28%-370.76K | -469.15%-99.22K | 71.96%-22.54K | 81.47%-80.84K | 76.50%-79.82K | 168.41%52.49K | 219.41%26.88K | -183.04%-80.4K | -252.26%-436.36K | -69.82%-339.63K |
| Change In working capital | 56.52%-146.37K | 135.99%163.32K | -202.08%-59.93K | 45.42%-1.07M | -458.82%-263.27K | -19.68%-336.67K | 68.46%-453.77K | 93.81%-19.84K | -332.64%-1.97M | -91.74%73.37K |
| -Change in receivables | 47.87%-53.39K | 110.75%36.25K | -118.34%-55.51K | 84.81%-41.78K | -44.98%95.05K | 47.93%-102.4K | -386.55%-337.05K | 266.37%302.62K | -50.15%-275.07K | -49.99%172.77K |
| -Change in prepaid assets | 25.41%-239.68K | 501.97%66.64K | 66.71%-122.16K | -31.89%-1.04M | -392.93%-337.79K | -102.10%-321.32K | 95.59%-16.58K | 1.04%-366.93K | -123.29%-790.55K | 131.19%115.32K |
| -Change in payables and accrued expense | -4,580.07%-39.69K | 199.03%37.68K | -97.09%3.81K | 120.34%191.06K | 127.31%99.01K | -100.73%-848 | 95.13%-38.05K | 50.47%130.95K | -180.52%-939.55K | -132.58%-362.55K |
| -Change in other current liabilities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---18.13K | ---- |
| -Change in other working capital | 112.03%186.38K | 136.65%22.76K | 231.74%113.93K | -420.66%-180.21K | -172.02%-119.53K | 307.99%87.9K | 70.78%-62.1K | -159.64%-86.48K | -73.98%56.2K | 182.80%165.96K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 1,142.12%415.06K | 413.84%361.15K | 103.59%224.35K | 84.76%-202.95K | -191.27%-231.48K | 111.12%33.42K | 87.36%-115.08K | 129.43%110.19K | -88.47%-1.33M | 205.15%253.62K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 32.09%-124.28K | -230.58%-483.08K | -261.76%-218.79K | 130.33%562.99K | 242.25%436.51K | -200.86%-183K | 136.35%369.96K | 91.52%-60.48K | -2,884.88%-1.86M | -123.03%-306.86K |
| Net PPE purchase and sale | --200K | 68.78%-4.27K | 68.53%-9.34K | 92.38%-55.52K | -118.75%-12.17K | --0 | 32.19%-13.68K | -35.17%-29.67K | -1,152.06%-728.56K | 270.61%64.91K |
| Net investment purchase and sale | -77.21%-324.28K | -210.42%-478.81K | -579.79%-209.45K | 159.29%668.51K | 220.69%448.68K | -119.62%-183K | 143.47%433.64K | 95.54%-30.81K | -28,117.84%-1.13M | -127.13%-371.77K |
| Net other investing changes | ---- | ---- | ---- | ---50K | --0 | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 32.09%-124.28K | -230.58%-483.08K | -261.76%-218.79K | 130.33%562.99K | 242.25%436.51K | -200.86%-183K | 136.35%369.96K | 91.52%-60.48K | -2,884.88%-1.86M | -123.03%-306.86K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -3.19%-40.48K | -3.23%-40.07K | 49.17%-40.06K | -110.11%-196.92K | -3.36%-40.06K | -128.46%-39.23K | -103.67%-38.81K | -109.95%-78.81K | 8.05%1.95M | -3.20%-38.76K |
| Net issuance payments of debt | -3.19%-40.48K | -3.23%-40.07K | 49.17%-40.06K | -29.98%-196.92K | -3.22%-40.06K | -4.44%-39.23K | -3.34%-38.81K | -109.83%-78.81K | -0.83%-151.49K | -3.34%-38.81K |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | -96.35%40K | -104.82%-40K | 7.95%2.14M | 42.80%36.35K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -42.60%-36.3K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -3.19%-40.48K | -3.23%-40.07K | 49.17%-40.06K | -110.11%-196.92K | -3.36%-40.06K | -128.46%-39.23K | -103.67%-38.81K | -109.95%-78.81K | 8.05%1.95M | -3.20%-38.76K |
| Net cash flow | ||||||||||
| Beginning cash position | -93.88%14.36K | 846.27%176.36K | 341.74%210.86K | -96.29%47.73K | -67.15%45.9K | 93.90%234.71K | -98.12%18.64K | -96.29%47.73K | 407.88%1.29M | -40.27%139.73K |
| Current changes in cash | 232.56%250.29K | -174.97%-161.99K | -18.58%-34.5K | 113.16%163.13K | 279.32%164.96K | -1,110.55%-188.81K | 124.81%216.07K | 90.15%-29.1K | -219.90%-1.24M | -108.73%-92K |
| End cash Position | 476.64%264.66K | -93.88%14.36K | 846.27%176.36K | 341.74%210.86K | 341.74%210.86K | -67.15%45.9K | 93.90%234.71K | -98.12%18.64K | -96.29%47.73K | -96.29%47.73K |
| Free cash from | 1,142.12%415.06K | 377.18%356.88K | 167.01%215.01K | 88.10%-258.47K | -202.15%-243.65K | 103.18%33.42K | 86.45%-128.76K | 119.70%80.53K | -184.11%-2.17M | 185.42%238.53K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.